Keywords: genzyme, transgenics, ph, i/ii, data, corp, idiotypic

Genzyme Transgenics: Ph I/II Data

Article | 11 December 1997

- Genzyme Transgenics Corp's idiotypic cancer vaccine has producedtumor-specific immune responses in six of seven follicular lymphoma patients, according to results ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing